Dossier
Charles Swanton
Coverage of Charles Swanton in the Nexus archive.
- Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story
A randomized trial of Grail’s Galleri multi-cancer early detection test, conducted with the U.K. National Health Service, showed no reduction in stage 3 and 4 cancers as its primary endpoint. An oncologist highlights additional context despite the negative trial results.